Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 2398 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
High-Tech Gründerfonds–RWE: investment, 201710 investment 7-digit € of RWE Generation SE in HTGF III Fund 2017-10-19
CureVac–Lilly: investment, 201710 equity investment $45m as part of mRNA cancer vaccines collaboration 2017-10-18
Lilly–CureVac: cancer vaccines, 201710– collab ww $50m upfront + $45m equity investment + $1.7b milestones up to 5 products using RNActive technology 2017-10-18
SurgVision–Bracco: investment, 201710 acquisition of SurgVision BV by Bracco Imaging SpA 2017-10-18
Institut Nehring–Eurofins: investment, 201710 acquisition of Institut Nehring GmbH by Eurofins 2017-10-16
Roche–Warp Drive Bio: drug discovery, 201710– strategic collab up to $387m plus royalties r+d of novel antibiotics using Genome Mining platform 2017-10-16
Apeiron–MC Services: public relations, 201710 service existent by MC Services AG 2017-10-13
InflaRx–Bain Capital: investment, 201710 financing round Series D totalling $30m incl co-lead investor Bain Capital Life Sciences LP 2017-10-13
InflaRx–Cormorant: investment, 201710 financing round Series D totalling $30m incl co-lead investor Cormorant Asset Management LLC 2017-10-13
InflaRx–RA Capital Management: investment, 201710 financing round Series D totalling $30m incl co-lead investor RA Capital Management LLC 2017-10-13
InflaRx–SEVERAL: investment, 201710 financing round Series D $30m capital increase co-led by Bain Capital LS + Cormorant + RA Capital 2017-10-13
CRISPR Therapeutics–Chardan: investor conference, 201710 supply service CRISPR presents at Chardan Gene Therapy Conference in New York 2017-10-12
CRISPR Therapeutics–Leucadia: investor conference, 201710 supply service CRISPR presents at Jefferies Gene Technology Investor Summit in New York 2017-10-12
Kohlberg Kravis Roberts–Eurofins: investment, 201710– acquisition of LGC Forensics division of LGC Group from KKR 2017-10-12
Nestlé–Codexis: therapeutic enzymes, 201710– collab strategic alliance using CodeEvolver platform + incl option for ww developm of CDX-6114 2017-10-12
Medical Univ Innsbruck–Helmholtz: IP services, 201710– service collab knowledge + technology transfer with Ascenion GmbH 2017-10-09
Chiome Bioscience–Minapharm: GlymaxX technology, 201710– service + license cell line developm for antibody production applying GlymaxX by ProBioGen 2017-10-05
Immatics–Amgen: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Hopp Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–SEVERAL: investment, 201710 financing round Series E $58m Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Strüngmann Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Wellington Partners: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Epiontis–Precision Medicine Group: investment, 201709 acquistion of Epiontis GmbH 2017-09-30
Eppendorf–Arburg: plastic moulding machine, 201709 supply of 100th Allrounder machine to Eppendorf Polymere GmbH 2017-09-29
Exscientia–Evotec: investment, 201709 investment €15m by Evotec AG to acquire minority stake in Exscientia Ltd 2017-09-28
Novartis–Univ California: drug discovery technology, 201709– collab establishment of Novartis-Berkeley Center for Proteomics & Chemistry Technologies 2017-09-28
Orgentec–Streck: laboratory equipment, 201709– distribution of Streck cell stabilisation + molecular products by Orgentec SASA in France 2017-09-28
Curetis–Ladenburg Thalmann: investor conference, 201709 supply service Curetis presents at Ladenburg Thalmann 2017 Healthcare Conference in NY 2017-09-26
Merlin Diagnostika–Bruker Corp: investment, 201709 acquisition €na by Bruker 2017-09-26
Sonic Healthcare–Bruker Corp: mass spectrometer, 201709 supply existent MLB is long-term user of MALDI Biotyper system 2017-09-26
ThromboGenics–Sachs Associates: investor conference, 201709 supply service ThromboGenics presents at Sachs Biotech in Europe Forum in Basel 2017-09-26
Curetis–Cantor Fitzgerald: investor conference, 201709 supply service Curetis presents at Cantor Fitzegerald Global Healthcare Conference in NY 2017-09-25
Nabriva–Cantor Fitzgerald: investor conference, 201709 supply service Nabriva presents at Cantor Fitzegerald Global Healthcare Conference in NY 2017-09-25
Humabs BioMed–Vir Biotechnology: investment, 201709 acquisition of Humabs by Vir 2017-09-21
Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich 2017-09-20
Juno Therapeutics–Celgene: investment, 201709 private placement $31.1m to Celgene with 758k shares at $41/share 2017-09-20
Juno Therapeutics–SEVERAL: investment, 201709 public offering $250.1m+$37.515m with 6.1m+915k shares at $41/share 2017-09-20
Nabriva–W2O Group: public relations, 201709 service existent PR by Pure Communications 2017-09-20
Bruker Corp–Bioinformatics Solutions: mass spectrometry software, 201709 collab existent using PEAKS Studio s/w for MS-based proteomics 2017-09-18
Bruker Corp–Max Planck: mass spectrometry, –201709 collab developm of PASEF technology for timsTOF Pro MS for proteomics with Matthias Mann 2017-09-18
Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich 2017-09-18
Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London 2017-09-18
High-Tech Gründerfonds–Evonik: investment, 201709 investment existent in HTGF III fund 2017-09-18
Nabriva–SEVERAL: investment, 201709 public offering $80m+$12m with 9.4m+1.4m ordinary shares at $6/share 2017-09-18
Numaferm–Evonik: investment, 201709 Evonik Venture Capital joins €7-digit seed financing round 2017-09-18
ThromboGenics–Novartis: investment, 201709– equity investment €10m by Novartis after termination of Jetrea agreement 2017-09-18
BioBridges–Adecco: investment, 201709 acquisition €na of BioBridges by Adecco Group 2017-09-14
Evotec–Bank of America: investor conference, 201709 supply service Evotec presents at BoAML Global Healthcare Conference London 2017-09-14
Ginkgo Bioworks–Bayer: investment, 201709– founding joint venture firm with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–SEVERAL: investment, 201709– founding joint venture with Bayer with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–Viking Global Investors: investment, 201709– founding Ginkgo/Bayer joint venture with $100m Series A from Ginkgo + BLSC + Viking 2017-09-14
Flagship Pioneering–Lipotype: lipid analysis, 201709c supply service lipid anaylsis for Flagship VentureLabs 2017-09-13
Genenta Science–SEVERAL: investment, 201709 financing round Series B €7m 2017-09-13
Sophia Genetics–SEVERAL: investment, 201709 financing round Series D $30m led by Balderton Capital 2017-09-13
Ayoxxa–MC Services: public relations, 201709 service existent by MC Services AG 2017-09-11
Bruker Corp–Morgan Stanley: investor conference, 201709 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY 2017-09-11
Evotec–Morgan Stanley: investor conference, 201709 supply service Evotec presents at Morgan Stanley Global Healthcare Conference NY 2017-09-11
Thermo Fisher–Morgan Stanley: investor conference, 201709 supply service Thermo Fisher presents at Morgan Stanley Global Healthcare Conference 2017-09-11
Curetis–Rodman & Renshaw: investor conference, 201709 supply service Curetis presents at Rodman & Renshaw Global Investment Conference in NY 2017-09-10
Rigontec–Merck (US): investment, 201709– acquisition €115m cash upfront + €349m milestones ANNOUNCED 2017-09-06
Amal Therapeutics–BioMedPartners: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BioMedPartners 2017-09-05
Amal Therapeutics–Boehringer: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BIVF 2017-09-05
Amal Therapeutics–Helsinn: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor Helsinn Investment Fund 2017-09-05
Amal Therapeutics–High-Tech Gründerfonds: investment, 201709 financing round Series B first closing totalling €8m incl co-investor HTGF 2017-09-05
Amal Therapeutics–Schroders: investment, 201709 financing round Series B first closing totalling €8m incl co-investor Schroder Adveq 2017-09-05
Amal Therapeutics–SEVERAL: investment, 201709 financing round Series B first closing €8m co-led by BIVF + BioMedPartners + Helsinn 2017-09-05
Amal Therapeutics–VI Partners: investment, 201709 financing round Series B first closing totalling €8m incl co-investor VI Partners 2017-09-05
Metabolomic Discoveries–Metabolon: investment, 201709 acquisition €na of Metabolomic Discoveries GmbH by Metabolon Inc 2017-09-05
Boehringer–Allcyte: drug discovery, 201709– collab using Pharmacoscopy ex vivo drug response profiling platform for BI oncology candidates 2017-09-04
Amcure–Germany (govt): grant, 201708 BMBF research grant €1.75m to advance clinical lead candidate AMC303 2017-08-31
Angiex–Merck (DE): drug development services, 201708– supply BioReliance End-to-End Solutions for developm of ADC therapy of Angiex Inc 2017-08-29
Apeiron–EU (govt): credit, 201708– EIB EFSI loan €25m to support developm of cancer drugs 2017-08-28
Kite Pharma–Gilead: investment, 201708– acquisition $11.9b cash tender offer $180/share ANNOUNCED 2017-08-28
Natrix Separations–Merck (DE): investment, 201708– acquisition €na of Natrix Separations by Merck ANNOUNCED 2017-08-28
Aurealis Pharma–SEVERAL: investment, 201708 financing round Series A CHF5.6m from private investors + Finnvera + Tekes 2017-08-25
Novartis–Xoma: IL-1 beta antibodies, 201708– license $26m upfront + $5m investment + milestones + royalties ww rights to gevokizumab + IL-beta Ab IP 2017-08-25
Labfolder–Germany (govt): business development, 201708– supply service support in US with German Accelerator Life Sciences programme 2017-08-24
Macrophage Pharma–Merck (DE): investment, 201708 financing round Series A extension with new investor Merk Ventures 2017-08-23
Batavia–UGA Biopharma: cell line development, –201708 collab devleopm of 2 enzmye expressing monoclonal cell lines for biopharma production 2017-08-22
CRISPR Therapeutics–Partners HealthCare: cell therapy, 201708– collab research + license option 2y w MGHCC develop cancer T cell therapies w CRISPR 2017-08-22
Lilly–Topas Therapeutics: immuno modulatory compounds, 201708– collab €na multi-y research + option agreem 2017-08-22
Micro-Sphere–Ramarketing: public relations, 201708– service by Ramarketing 2017-08-22
AstraZeneca–Ethris: mRNA-based therapeutics, 201708– collab research 5y w €25m upfront + funding + milestones using SNIM®RNA technology 2017-08-21
Ethris–MacDougall Biomedical Communications: public relations, 201708 service existent by MacDougall 2017-08-21
Biotecon–Bruker Corp: mass spectrometer, 201708– distribution OEM of MALDI Biotyper platforms for food analysis in DACH region + Eastern Europe 2017-08-16
Monsanto–ToolGen: CRISPR technology, 201708– license ww €na for use of ToolGen’s CRISPR technology platform in agricultural products 2017-08-16
Roche–Mimetas: organ-on-a-chip technology, –201708 collab developm gut model on-a-chip using OrganoPlate platform 2017-08-16
Purdue Pharma–CellAct: cancer drug, 201708– acquisition ww developm + commerc rights to CAP7.1 by Mundipharma from CellAct 2017-08-14
Roivant–SEVERAL: investment, 201708 financing round $1.1b led by SoftBank Vision Fund + incl Dexxon investor group 2017-08-09
Roivant–SoftBank: investment, 201708 financing round totalling $1.1b incl new + lead investor SoftBank Vision Fund 2017-08-09
Diagnosticum (HU)–Bruker Corp: food analysis, 201708 collab to form Hungarian Wine Consortium using NMR FoodScreener for wine analysis 2017-08-08
IFM Therapeutics–BMS: investment, 201708– acquisition 100% for $300m upfront + up to $2.02b milestones 2017-08-03
Bruker Corp–OTHER: immunoassay technology, 201708 acquisition €na of portable chip-based ELISA platform by Bruker 2017-08-02
Homology Medicines–HBM: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor HBM Healthcare Investments 2017-08-01
Homology Medicines–Novartis: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor Novartis 2017-08-01
Homology Medicines–SEVERAL: investment, 201708 financing round Series B $83.5m led by Deerfield Management 2017-08-01
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px